Pay in 4 interest-free payments of $6.40 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
The bioavailability problem Absorption comparison: Injection: 80-100% bioavailability (nearly all absorbed) Nasal spray: 30-70% bioavailability (varies by peptide) Oral: 0-5% bioavailability (most peptides destroyed) Why nasal lower than injection: Must penetrate nasal mucosa (barrier) Some drips down throat (swallowed = lost) Variable absorption efficiency Technique-dependent Individual variation high What this means: You need MORE peptide via nasal spray Typically 2-3x higher dose than injection Example: 1mg injection = 2-3mg nasal Increases cost significantly But still cheaper/easier than injection for some Conversion guidelines by peptide PT-141: Injection: 1.5-2mg typical dose Nasal equivalent: 3-5mg Conversion ratio: 2-3x Semax: Designed for nasal use (no conversion needed) Standard nasal dose: 200-600mcg per spray 2-3 sprays per nostril typical Follow product guidelines BPC-157 (if attempting nasal): Injection: 250-500mcg Nasal (estimated): 750-1500mcg But: Injection or oral likely better Nasal BPC-157 not well-studied General conversion approach: Start with 2-3x injection dose Assess results after 2-3 uses Increase by 25-50% if weak effects Find minimum effective nasal dose Individual variation significant Cost implications: Using 2-3x more peptide = 2-3x cost Nasal spray more expensive per dose Trade-off: Convenience vs cost Worth it for needle-phobic Not worth it if injections acceptable Use peptide cost calculator to compare routes
Enter the peptide amount (mg), the bacteriostatic water you add (mL), and your desired dose
This mechanism enhances fat metabolism and supports body composition improvement without affecting blood glucose, insulin sensitivity, or IGF-1 levels like full-length growth hormone would
BPC 157 Therapy: Targeting Angiogenesis and Nitric Oxide's Cytotoxic and Damaging Actions, but Maintaining, Promoting, or Recovering Their Essential Protective Functions
5-Amino-1MQ for Diabetes and Metabolic Disorders NNMT is a potential biomarker for reduced insulin sensitivity, since higher activity of this enzyme has been linked to insulin resistance and type 2 diabetes [9]
